Improved overall survival with checkpoint inhibition and allogeneic transplantation in relapsed Hodgkin lymphoma

Improved overall survival with checkpoint inhibition and allogeneic transplantation in relapsed Hodgkin lymphoma

Abstract: Patients with relapsed classic Hodgkin lymphomas (cHLs) receive salvage therapy with immune checkpoint inhibitors (ICIs) or chemotherapy (no-ICI). Patients responding to therapy often undergo consolidation with allogeneic blood or marrow transplantation (alloBMT). We previously reported th...

Full description

Saved in:
Bibliographic Details
Main Authors: Nadeem Tabbara, Marianna Zahurak, Cole H. Sterling, Iris Margalit Trutzer, Jaroslaw Jedrych, Lode J. Swinnen, Ephraim J. Fuchs, Javier Bolaños-Meade, Nina Wagner-Johnston, Richard J. Jones, Richard F. Ambinder, Ravi Varadhan, Suman Paul
Format: Article
Language:English
Published: Elsevier 2025-03-01
Series:Blood Advances
Online Access:http://www.sciencedirect.com/science/article/pii/S2473952924007328
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first

Similar Items